The role of inflammation and anti-inflammatory therapy in irritable bowel syndrome (review and results of own research)
Journal Title: Сучасна гастроентерологія - Year 2019, Vol 0, Issue 1
Abstract
The paper presents relevant data on the pathogenetic role of intestinal mucous inflammation at irritable bowel syndrome (IBS). It has been shown that with some IBS subtypes, especially post-infectious IBS, the inflammation may be of key significance in the developing of low-intensity inflammatory reaction and symptoms emergence. Mast cells, intestinal barrier dysfunction, intestinal pathogens and genetic predisposition are of great importance in the development of such inflammation. In IBS patients the inflammation may be a part of disease pathogenesis, which requires further study. Thus, IBS pathogenetic treatment may include anti-inflammatory agents, such as Mesalazine, Ketotifen and Sodium Cromoglycate, steroids, Omalizumab. The results of own investigation demonstrated that Montelukast in combination with Quifenadine as an adjunctive of the standard baseline therapy increased the treatment efficacy in IBS patients with concomitant allergic diseases, especially IBS-D subtype. In particular, both allergic and gastroenterological manifestations were reduced, pain intensity and diarrhea syndrome significantly attenuated, the overall health, vitality and physical condition of patients improved. These changes took place owing to following effects of combined therapy: blocking of the inflammatory mediators in mast cells, anti-spasmodic and desensitizing effects with additional relief of the constrictive and spasmogenic histamine effects on smooth muscles of the intestine. Moreover, Quifenadine has a moderate anti-serotonin effect which, plays an important role in IBS, taking into account its pathophysiological mechanisms. Thus, the combination of anti-leukotriene and antihistamines, along with the baseline therapy in patients with IBS and associated allergic diseases, provides a positive clinical and laboratory outcome, but requires further study.
Authors and Affiliations
A. R. Levchenko
Keywords
Related Articles
- EP ID EP508587
- DOI 10.30978/MG-2019-1-113
- Views 109
- Downloads 0
A clinical case of rare vascular lesion of the large intestine
The article presents a clinical case of a hemangioma of the large intestine. The patient was observed for ulcerative colitis and hemorrhoidal hemorrhages for a long time and received appropriate treatment. Performing a s...
The role of vegetative and emotional disorders in the chronization of duodenal peptic ulcer
Objective — to define the role of vegetative and emotional disorders in the chronization of duodenal peptic ulcer (DPU). Materials and methods. The study involved 62 patients (39 men і 23 women) with DPU, aged 18 to 42...
The role of pentraxine-3 and the new non-invasive methods in the diagnostics of non-alcoholic steatohepatitis
This review is devoted to the diagnosis of one of the most common pathologies of the modern world — non-alcoholic fatty liver disease. The new non-invasive methods for the diagnosing of non-alcoholic steatohepatitis have...
Dermatological paraneoplastic syndromes in gastroenterology: prediction of the inevitable or guidance to action? Part I
This article presents information on paraneoplastic syndromes (PNS) — various pathologies and conditions that accompany and sometimes precede the onset of malignant visceral neoplasms. Although some of the PNS and neopla...
Novelties in the treatment of inflammatory bowel disease: outcome of the symposium 213 by the Falk Foundation
-